• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道间质瘤中原发肿瘤和配对转移灶中的 miRNA 图谱。

miRNA landscape in primary tumors and matched metastases in gastrointestinal stromal tumors.

机构信息

Department of Pharmacy & Biotechnology, University of Bologna, 40126 Bologna, Italy.

Sarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.

出版信息

Epigenomics. 2021 Mar;13(5):369-377. doi: 10.2217/epi-2020-0303. Epub 2021 Jan 12.

DOI:10.2217/epi-2020-0303
PMID:33432846
Abstract

Gastrointestinal stromal tumor management is extremely challenging, particularly the metastatic disease. The underlying mechanism in metastasis spread remains largely unknown. We aimed to characterize miRNAs involved in the metastatic process in gastrointestinal stromal tumor. Eight primary tumors and 18 synchronous metastases were analyzed through miRNA Taqman arrays or assays. miRNAs profiles revealed similar expression in primary site and metastases. Pair-wise correlation coefficient between primary tumor and metastases was significant for each patient (p < 0.0001 for all profiled patients). Our study, the largest including primary tumors and metastases so far performed, highlighted perpetuation of miRNAs features in metastatic lesions and that the primary origin appears to be the main determinant of the metastases miRNA profile.

摘要

胃肠道间质瘤的治疗极具挑战性,尤其是转移性疾病。转移扩散的潜在机制在很大程度上仍然未知。我们旨在描述胃肠道间质瘤转移过程中涉及的 miRNAs。通过 miRNA Taqman 微阵列或检测分析了 8 个原发肿瘤和 18 个同步转移灶。miRNA 谱显示原发灶和转移灶的表达相似。每个患者的原发肿瘤与转移灶之间的成对相关系数均有显著意义(所有患者的 p < 0.0001)。我们的研究是迄今为止最大规模的包括原发肿瘤和转移灶在内的研究,突出了转移灶中 miRNAs 特征的持续存在,并且原发灶似乎是转移灶 miRNA 谱的主要决定因素。

相似文献

1
miRNA landscape in primary tumors and matched metastases in gastrointestinal stromal tumors.胃肠道间质瘤中原发肿瘤和配对转移灶中的 miRNA 图谱。
Epigenomics. 2021 Mar;13(5):369-377. doi: 10.2217/epi-2020-0303. Epub 2021 Jan 12.
2
Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GIST.浆膜受累/壁外生长对胃肠道间质瘤同步和异时性腹膜播散风险的影响:胃肠道间质瘤宏观分类的建议
Int J Clin Exp Pathol. 2012;5(1):12-22. Epub 2012 Jan 1.
3
A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.胃肠道间质瘤中表观遗传沉默的微小RNA基因筛查
PLoS One. 2015 Jul 27;10(7):e0133754. doi: 10.1371/journal.pone.0133754. eCollection 2015.
4
[Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors].[交界性与恶性胃肠道间质瘤中差异表达微小RNA的筛选]
Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):20-5. doi: 10.3760/cma.j.issn.0529-5807.2013.01.005.
5
Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.高通量定量逆转录聚合酶链反应微阵列揭示胃肠道间质瘤中微小RNA的表达谱
World J Gastroenterol. 2015 May 21;21(19):5843-55. doi: 10.3748/wjg.v21.i19.5843.
6
Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor.血清miR-518e-5p是继发性伊马替尼耐药胃肠道间质瘤的潜在生物标志物。
J Biosci. 2018 Dec;43(5):1015-1023.
7
The rs17084733 variant in the 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility.rs17084733 变异位于 3'UTR 区,破坏了胃肠道间质瘤中 miR-221/222 的结合位点:一种具有疾病易感性的海绵样机制。
Epigenetics. 2019 Jun;14(6):545-557. doi: 10.1080/15592294.2019.1595997. Epub 2019 Apr 13.
8
Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.长期甲磺酸伊马替尼辅助治疗广泛手术切除伴腹膜转移的破裂小肠胃肠道间质瘤的疗效:1 例报告。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620970736. doi: 10.1177/2324709620970736.
9
Primary surgery as a frontline treatment for synchronous metastatic gastrointestinal stromal tumors: an analysis of the Kinki GIST registry.原发性手术作为同步转移性胃肠道间质瘤的一线治疗:来自近畿胃肠道间质瘤登记处的分析
Surg Today. 2016 Sep;46(9):1068-75. doi: 10.1007/s00595-015-1282-4. Epub 2015 Nov 26.
10
Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature.胃肠道间质瘤(GIST)患者的其他原发性恶性肿瘤:一项对260例患者的临床病理研究及分子分析与文献复习
Ann Surg Oncol. 2015 Aug;22(8):2633-9. doi: 10.1245/s10434-014-4332-z. Epub 2015 Jan 7.

引用本文的文献

1
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST.KIT 突变和表达:克服 GIST 中 IM 耐药的最新知识和新见解。
Cell Commun Signal. 2024 Feb 27;22(1):153. doi: 10.1186/s12964-023-01411-x.
2
Secreted microRNAs in bone metastasis.骨转移中的分泌型 microRNAs。
J Bone Miner Metab. 2023 May;41(3):358-364. doi: 10.1007/s00774-023-01424-z. Epub 2023 Apr 8.